Technology in Haematology and Oncology Research

The complex drug development market faces increasing costs and high risks, and clients are eager to leverage services and technology to increase their return on investment and gain efficiencies.

To help clients and partners accelerate the delivery of safe and effective therapeutics and maximise the returns on their R&D investments, GCR utilises a variety of strategies and resources, including advanced trial design methodologies and state-of-the-art technologies.

Haematology and Oncology Technology

Medical Imaging

GCR offers an integrated and seamless approach to clinical development and medical imaging for oncology research.

GCR expedites clients’ oncology clinical trials with best-in-class, comprehensive clinical development and medical imaging services.

This unique offering provides:

  • A strategically integrated approach that allows clients to benefit from efficiencies and make fast, confident decisions
  • Tailored solutions designed to meet the unique needs of each client’s oncology development program and quickly progress their therapies from early phase to regulatory approval
  • Seamless integration of technologies and processes, giving biopharmaceutical companies near real-time, consistent and reliable medical imaging information to expedite their drug development programs